Ceragon Confirms Q4 & FY 2025 Results, Reiterates Strong 2026 Guidance, and Strengthens Balance Sheet
summarizeSummary
Ceragon Networks confirmed its Q4 and full-year 2025 financial results, reiterated positive 2026 guidance, and reported a strengthened balance sheet with increased net cash and North American backlog.
check_boxKey Events
-
Confirms Q4 & FY 2025 Financial Results
Reported Q4 2025 revenues of $82.3 million and full-year 2025 revenues of $338.7 million, consistent with preliminary results announced on January 8, 2026.
-
Reiterates Strong 2026 Guidance
Maintained 2026 revenue guidance of $355 million to $385 million, implying near double-digit growth, and non-GAAP operating margin of 6.5% to 7.5% at the midpoint.
-
Strengthened Balance Sheet
Ended 2025 with $38.4 million in cash and cash equivalents, increasing its net cash position to $19.4 million from $10.1 million at the end of 2024, reflecting improved cash generation.
-
Increased North American Backlog
Backlog entering 2026 is nearly double what it was entering 2025, indicating strong momentum in the North American market.
auto_awesomeAnalysis
This 6-K filing confirms Ceragon Networks' preliminary fourth quarter and full-year 2025 financial results, which were previously disclosed on January 8, 2026. The company reported Q4 revenues of $82.3 million and full-year revenues of $338.7 million, aligning with prior expectations. Notably, Ceragon reiterated its 2026 revenue guidance of $355 million to $385 million, implying near double-digit growth. The filing also highlighted a strengthened balance sheet, with a net cash position increasing to $19.4 million from $10.1 million at the end of 2024, driven by improved cash generation and a significantly higher backlog in North America. While the core financial outlook was previously known, the detailed confirmation and positive balance sheet developments provide further clarity and confidence.
At the time of this filing, CRNT was trading at $2.28 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $203.2M. The 52-week trading range was $1.82 to $3.68. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.